Lawrence B. Cohen’s Pfizer PFE Stock Holding History

Lawrence B. Cohen’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-6,866	Closed	-$352K	–	82
2022 Q4	$352K	Buy	+6,866	New	+$329K	0.18%	81
2022 Q1	–	Sell	-7,056	Closed	-$417K	–	87
2021 Q4	$417K	Buy	+7,056	New	+$350K	0.16%	71
2020 Q4	–	Sell	-6,049	Closed	-$211K	–	75
2020 Q3	$211K	Buy	+6,049	New	+$212K	0.13%	70
2020 Q2	–	Sell	-10,291	Closed	-$319K	–	75
2020 Q1	$319K	Buy	10,291 +3,457	+51%	+$118K	0.25%	60
2019 Q4	$254K	Sell	6,834 -2,846	-29%	-$101K	0.15%	70
2019 Q3	$330K	Buy	9,680 +2,846	+42%	+$103K	0.22%	66
2019 Q2	$281K	Buy	6,834 +1,693	+33%	+$67.2K	0.19%	65
2019 Q1	$207K	Sell	5,141 -590	-10%	-$23.6K	0.15%	67
2018 Q4	$237K	Buy	5,731 +638	+13%	+$26.5K	0.18%	65
2018 Q3	$213K	Buy	+5,093	New	+$196K	0.14%	67
2017 Q2	–	Sell	-6,207	Closed	-$201K	–	77
2017 Q1	$201K	Buy	+6,207	New	+$196K	0.12%	74
2016 Q3	–	Sell	-7,750	Closed	-$259K	–	79
2016 Q2	$259K	Buy	7,750 +200	+3%	+$6.38K	0.15%	81
2016 Q1	$212K	Hold	7,550	–	–	0.14%	69
2015 Q4	$231K	Sell	7,550 -843	-10%	-$26.5K	0.16%	66
2015 Q3	$250K	Buy	8,393 +208	+3%	+$6.67K	0.17%	64
2015 Q2	$260K	Hold	8,185	–	–	0.16%	62
2015 Q1	$270K	Sell	8,185 -780	-9%	-$24.8K	0.16%	62
2014 Q4	$265K	Buy	8,965 +345	+4%	+$9.89K	0.16%	64
2014 Q3	$242K	Hold	8,620	–	–	0.16%	66
2014 Q2	$243K	Hold	8,620	–	–	0.16%	63
2014 Q1	$263K	Hold	8,620	–	–	0.18%	61
2013 Q4	$250K	Sell	8,620 -158	-2%	-$4.6K	0.18%	60
2013 Q3	$239K	Sell	8,778 -3,537	-29%	-$96.2K	0.18%	60
2013 Q2	$327K	Buy	+12,315	New	+$340K	0.24%	51

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Lawrence B. Cohen's PFE Position: Q1 2023 in Review

Lawrence B. Cohen sold out of Pfizer (PFE) in Q1 2023, closing a stake of 6,866 shares — an estimated $352K sold.

Lawrence B. Cohen first reported a position in PFE in Q2 2013 and held it in 24 quarters. The position peaked at $417K in Q4 2021. 3,103 funds tracked by Wall St. Rank hold PFE as of Q1 2023.

Lawrence B. Cohen reported no remaining Pfizer position as of Q1 2023 after selling out during the quarter.
Lawrence B. Cohen sold 6,866 Pfizer shares in Q1 2023, an estimated $352K.
Lawrence B. Cohen first reported a position in Pfizer in Q2 2013 and held it in 24 quarters.
Lawrence B. Cohen's Pfizer position peaked at $417K in Q4 2021.
3,103 funds tracked by Wall St. Rank held Pfizer as of Q1 2023.

Based on Lawrence B. Cohen's 13F filing for Q1 2023, filed 11 May 2023.